Pro-QCP SAMPLE REPORT
|
|
- Bernadette Owen
- 5 years ago
- Views:
Transcription
1 Pro-QCP SAMPLE REPORT 2016 CarePoint Solutions, Inc. All rights reserved. General Hospital 123 N Main St New York, NY 12345
2 What is an IQCP? The Individualized Quality Control Plan (IQCP) is the Clinical Laboratory Improvement Amendments (CLIA) Quality Control (QC) policy currently under development as an alternate QC option allowed by 42CFR The guidance and concepts for IQCP are a formal representation and compilation of many things laboratories already do to ensure quality test results. IQCP permits the laboratory to customize its QC plan according to test method and use, environment, and personnel competency while providing for equivalent quality testing. Individualized Quality Control Plan (IQCP). (2015, November 12). Retrieved November 30, 2015, from and- Guidance/legislation/CLIA/Individualized_Quality_Control_Plan_IQCP.html About Pro-QCP by CarePoint Solutions, Inc. Pro-QCP is an online, web-based software program that facilitates the creation of Individualized Quality Control Plans (IQCP s) consistent with EP-23 guidelines. This specialized program was designed to simplify and streamline the process of developing comprehensive IQCP s with the goal of improving patient outcomes. Pro-QCP is available by annual subscription with modules specific to the risks of each test device or method. For more information on Pro-QCP visit:
3 Program Information Program Information CLIA Number Accrediting Agency Test System Consumable Analytes 12D CAP (College of American Pathologists) i-stat CG4+ ph, po2, pco2, Lac Testing Locations Locations of testing which are considered in this IQCP ED ICU NICU
4 Risk Assessment Risk Matrix Severity of Harm Probability of Harm Negligible Minor Serious Critical Catastrophic Frequent Unacceptable Unacceptable Unacceptable Unacceptable Unacceptable Probable Acceptable Unacceptable Unacceptable Unacceptable Unacceptable Occasional Acceptable Acceptable Unacceptable Unacceptable Unacceptable Remote Acceptable Acceptable Acceptable Unacceptable Unacceptable Improbable Acceptable Acceptable Acceptable Acceptable Acceptable Figure 1 Rating scale developed by the Department of Clinical Effectiveness and Quality Improvement, University of Pennsylvania Health System. "Using FMEA to Improve Patient Safety: Part II". (2013, December, 13). Retrieved November , from Tennessee Center for Patient Safety Website Severity Ratings Severity Scoring - How bad will it be if this risk occurs? 5 Catastrophic Death or serious physical or psychological injury or the risk thereof. Serious injury specifically includes loss of limb or function. Must meet two of the three criteria: 1. Results in unanticipated death or major permanent loss of function 2. Associated with a significant deviation from the usual process 3. It has the potential for undermining the public confidence 4 Critical Injury or permanent loss of bodily function (sensory, motor, physiologic, or intellectual), disfigurement, surgical intervention required, increased LOS, increased level of care. 3 Serious An event, occurrence, or situation involving the clinical care of a patient in a medical facility which could have injured the patient but did not cause an unanticipated injury or require the delivery of additional healthcare services 2 Minor Failure is not noticeable to the patient and would not affect delivery of care. Failure can be overcome with modifications to the process; failure may cause minor injury. 1 Negligible (near miss) A process variation that does not affect the outcome but for which a recurrence carries a significant chance of a serious outcome. No injury, no increased LOS or level of care.
5 Probability Ratings Probability Scoring - How often might this hazard occur? Risk Assessment 5 Frequent Once per week 4 Probable Once per month 3 Occasional Once per year 2 Remote Once every three years 1 Improbable Once in the lifetime of the test system Scoring - Will someone notice before the hazard affects the patient? Rating Absolute uncertainty Remote Low Moderately high Almost certain Detection Probability Description <10% Potential failure mode and susbsequent cannot be detected in time for adequate intervention <25% Remote chance the potential failure mode and subsequent will be detected in time for adequate intervention <50% Low chance the potential failure mode and subsequent will be detected in time for adequate intervention <80% Moderately high chance the potential failure mode and susbsequent will be detected in time for adequate intervention <99% The potential failure mode and susbsequent will be detected in time for adequate intervention
6 Risk Assessment Hazard Identification Hazard Identification is a term which encompasses activities involved in identifying hazards and evaluating risk in healthcare, throughout the continuum of care, to make certain that risks to the patient are consistently controlled within the organization s risk tolerance. These activities typically address three main risk questions to a level of detail commensurate with analysis objectives, available information, and resources at hand. The three main risk questions are: Hazard What can go wrong? Severity How bad could it be? Probability How often might it happen? Risk Categories Specimen Encompasses the order, patient id, collection, and transfer of the patient Test System Encompasses the instrument, software, data entry, accessories, and all other components not associated with the or reagents Reagent Includes the test consumable (strip, cartridge, cuvette, etc), quality control materials (liquid, optical and electronic), calibration verification or linearity materials or any other components directly tested Environment Includes the patient care and/or testing areas and all aspects of human factors which might adversely affect the test result Testing Personnel Includes personnel who perform the test, care for the patient, manage the system, or troubleshoot problems
7 Fishbone Diagram (Ishikawa) Risk Assessment The fishbone diagram identifies many possible hazards which cause an incorrect test result. It can be used to structure a brainstorming session. It immediately sorts ideas into useful categories. The problem or is displayed at the head or mouth of the fish. Possible contributing causes are listed on the smaller bones under various cause categories. A fishbone diagram can be helpful in identifying possible causes for a problem that might not otherwise be considered by directing the team to look at the categories and think of alternative causes.
8 Risk Assessment by CarePoint Solutions -QCP
9 Risk Assessment Specimen Risks Low Risk The following risks were scored as ACCEPTABLE and may or may not have a Quality Control Plan (QCP) in. S-001 Test is performed without an order Minor Improbable Acceptable Low Yes No Acceptable S-002 Test is ordered outside the Indications for Use Minor Improbable Acceptable Yes No Acceptable S-003 Test is ordered outside the Limitations of Use Minor Improbable Acceptable Yes No Acceptable S-004 Patient is injured during collection Minor Remote Acceptable Yes No Acceptable S-005 Sample is collected from the wrong patient Minor Improbable Acceptable Yes No Acceptable S-006 Wrong patient ID is entered into the handheld Serious Improbable Acceptable Yes No Acceptable S-007 Sample is mislabeled Serious Improbable Acceptable Yes No Acceptable S-008 Collection supplies are out of tolerance, misused, or expired S-009 Sample is drawn in the wrong container type (tube, syringe, capillary tube) S-010 Sample is contaminated with alcohol or cleansing agent from prep S-011 Sample quantity is insufficient due to poor circulation or access S-012 Sample quantity is insufficient due to poor technique S-013 Sample is collected by improper access method (venous, arterial, capillary) Minor Improbable Acceptable Yes No Acceptable Minor Improbable Acceptable Yes No Acceptable Minor Improbable Acceptable Yes No Acceptable Minor Improbable Acceptable Yes No Acceptable Minor Improbable Acceptable Yes No Acceptable Minor Remote Acceptable Yes No Acceptable S-014 Syringe is not evacuated of ambient air Negligible Improbable Acceptable Yes No Acceptable S-015 Wrong type of container anticoagulant is selected Minor Improbable Acceptable Yes No Acceptable S-016 Sample is diluted with IV anticoagulant or fluid Minor Remote Acceptable Yes No Acceptable
10 Risk Assessment S-017 Sample is contaminated with bubbles Negligible Remote Acceptable Yes No Acceptable S-018 Sample is clotted Minor Occasional Acceptable Yes No Acceptable S-019 Sample is not properly mixed before infusing into the cartridge S-020 Sample is transported or left sitting for an extended period of time Minor Improbable Acceptable Yes No Acceptable Negligible Improbable Acceptable Yes No Acceptable S-021 Sample is improperly iced Minor Improbable Acceptable Yes No Acceptable S-022 Patient test is not repeated when result does not match patient condition and therapy S-023 Patient is suffering from anemia or polycythemia beyond the capabilities of the test system S-024 Patient is receiving interfering drugs beyond the parameters listed in product labeling Minor Remote Acceptable Yes No Acceptable Minor Remote Acceptable Yes No Acceptable Minor Remote Acceptable Yes No Acceptable
11 Risk Assessment Test System Risks Low Risk The following risks were scored as ACCEPTABLE and may or may not have a Quality Control Plan (QCP) in. T-001 Patient is injured during the test process Minor Improbable Acceptable No No Acceptable T-002 Patient is given a nosocomial infection Serious Remote Acceptable No No Acceptable T-003 Patient is dissatisfied with test system Negligible Improbable Acceptable No No Acceptable T-004 Product recall affects test system or cartridge use Minor Improbable Acceptable No No Acceptable T-005 Handheld is not properly validated T-006 Maintenance is performed improperly Negligible Remote Acceptable No No Acceptable T-007 Handheld is not regularly cleaned Negligible Remote Acceptable No No Acceptable T-008 Thermal Probe malfunctions T-009 Handheld malfunctions or is not calibrated properly T-010 Self-test or calibration does not run or fails Negligible Remote Acceptable No No Acceptable T-011 Internal simulator is not scheduled to run frequently T-012 Software is not regularly/properly updated on the handheld T-013 Customizations are not properly programmed or transferred to the handheld T-014 Handheld is not charged or power is not available for patient testing T-015 Patient test is performed on test system which is out of control Negligible Improbable Acceptable No No Acceptable Minor Occasional Acceptable No No Acceptable Negligible Remote Acceptable No No Acceptable
12 Risk Assessment T-016 Handheld is used for patient testing after a drop or impact T-017 Sample is not run in the proper analysis mode on the handheld T-018 Sample type (venous, arterial, capillary, etc) is improper for the test or improperly identified in the handheld T-019 Incorrect or un-ordered analytes are selected on the handheld T-020 Incorrect temperature is entered into the handheld T-021 Incorrect patient hemodynamic variables are entered into the handheld T-022 Handheld is not used on a stationary, horizontal surface Negligible Remote Acceptable No No Acceptable Minor Improbable Acceptable No No Acceptable Negligible Remote Acceptable No No Acceptable T-023 Handheld is disturbed during a patient test Negligible Improbable Acceptable No No Acceptable T-024 Patient result is clinically different on different handheld T-025 Use errors during pre-analytical or postanalytical test phases are not identified T-026 Cartridge is removed from the cartridge port before the result is reviewed T-027 Error messages which indicate bad patient result is misinterpreted T-028 Patient results are not recorded before handheld memory is exceeded T-029 Patient result is reported outside of the handheld Analytical Measurement Range (AMR) T-030 Results interface fails to transmit or corrupts results Minor Improbable Acceptable No No Acceptable Negligible Remote Acceptable No No Acceptable Minor Improbable Acceptable No No Acceptable Minor Improbable Acceptable No No Acceptable Minor Improbable Acceptable No No Acceptable
13 T-031 Patient result is misinterpreted due to incorrect or incomplete demographic or clinical data T-032 Patient result is misinterpreted due to test system idiosyncrasies Risk Assessment Minor Improbable Acceptable No No Acceptable T-033 Clinician fails to act on critical results Serious Remote Acceptable Remote Yes No Acceptable
14 Risk Assessment Reagent Risks Low Risk The following risks were scored as ACCEPTABLE and may or may not have a Quality Control Plan (QCP) in. R-001 Substantial change in reagent properties or system components cause clinical errors R-002 Cartridge or reagent is not available when needed Minor Occasional Acceptable No No Acceptable R-003 Cartridge is stored improperly Negligible Remote Acceptable No No Acceptable R-004 Cartridge is used beyond manufacturer's expiration date R-005 Cartridge is used beyond the room temperature expiration date Negligible Remote Acceptable No No Acceptable Minor Improbable Acceptable No No Acceptable R-006 Cartridge is mishandled Minor Improbable Acceptable No No Acceptable R-007 Sample is forced into the cartridge Negligible Remote Acceptable No No Acceptable R-008 Cartridge is underfilled or overfilled Negligible Improbable Acceptable No No Acceptable R-009 Cartridge is inserted into the cartridge port with blood on the outside Negligible Remote Acceptable No No Acceptable R-010 Cartridge is reused R-011 Liquid control is used as a calibrator R-012 Liquid control is not properly refrigerated R-013 Liquid control is used beyond the manufacturer's expiration date R-014 Liquid control is used beyond the room temperature expiration date R-015 Liquid control is not properly brought to room temperature before use Negligible Improbable Acceptable No No Acceptable Negligible Improbable Acceptable No No Acceptable
15 Risk Assessment R-016 Liquid control is not properly mixed Minor Improbable Acceptable No No Acceptable R-017 Liquid control results fall outside of expected values range for each lot R-018 Liquid control limits do not test an instrument malfunction which affects patient results R-019 Calibration verification controls are not properly refrigerated R-020 Calibration verification controls are used beyond the manufacturer's expiration date R-021 Calibration verification controls are used beyond the room temperature expiration date R-022 Calibration verification controls are not properly brought to room temperature before use R-023 Calibration verification controls are not properly mixed R-024 Calibration verification controls results fall outside of expected values range for each lot R-025 Calibration verification controls do not verify the entire patient result range R-026 Internal simulator Is not performed on every day of patient testing R-027 External simulator is not performed on every day of patient testing R-028 External simulator results fall outside of expected values range R-029 Reagent or cartridge was exposed to improper environmental conditions during shipment Negligible Improbable Acceptable No No Acceptable Minor Improbable Acceptable No No Acceptable Negligible Remote Acceptable No No Acceptable Negligible Improbable Acceptable No No Acceptable Negligible Improbable Acceptable No No Acceptable Negligible Remote Acceptable No No Acceptable Minor Improbable Acceptable No No Acceptable Negligible Improbable Acceptable No No Acceptable Negligible Improbable Acceptable No No Acceptable
16 Risk Assessment Environment Risks Low Risk The following risks were scored as ACCEPTABLE and may or may not have a Quality Control Plan (QCP) in. E-001 Handheld is not used within expected temperature and humidity range E-002 Noise affects test personnel concentration during testing E-003 Poor lighting or glare affects data entry or result interpretation E-004 Workplace clutter affects test personnel concentration or test process E-005 Inadequate workspace affects test personnel concentration or test process E-006 Personal devices affect test personnel concentration during testing E-007 Conversation affects test personnel concentration during testing E-008 Short staffing affects test personnel concentration during testing E-009 Interruptions affects test personnel concentration during testing E-010 Fibers, fluids, dust, or debris affect the test system E-011 Test system is subjected to unexpected barometric pressure Minor Improbable Acceptable No No Acceptable Negligible Remote Acceptable No No Acceptable Negligible Improbable Acceptable No No Acceptable Negligible Improbable Acceptable No No Acceptable Serious Improbable Acceptable No No Acceptable Minor Improbable Acceptable No No Acceptable Negligible Improbable Acceptable No No Acceptable
17 Risk Assessment Testing Personnel Risks Low Risk The following risks were scored as ACCEPTABLE and may or may not have a Quality Control Plan (QCP) in. P-001 Unqualified or expired test personnel perform patient testing P-002 Test personnel are not equipped to perform necessary troubleshooting Minor Improbable Acceptable No No Acceptable
18 Quality Control Plan Quality Control Plan The following risks are mitigated through positive action by policy, training, quality control, surveillance, calibration, and other activities which increase detection of hazards and improve prevention. This section explains the actions taken to mitigate or detect each risk. Specimen Risks S-001 Test is performed without an order Minor Improbable Acceptable Low Yes No Acceptable Chart audit Consistent implementation of the error detection system(s) defined in the procedure Track percent of ordered tests with patient identification errors Track percent of results with identification errors Track percent of patient results which are corrected Written or electronic orders are required Verbal test are followed up with a written or electronic order Every patient test Within 30 days Verbal orders are read back Immediately Entire order is read back Handheld configuration option or forcing function is in place At all times Verified by the Technical Consultant This risk is covered by our Written Policy This risk is covered during our Quiz
19 Quality Control Plan S-002 Test is ordered outside the Indications for Use Minor Improbable Acceptable Yes No Acceptable Retesting by a different method or device Unusual patient results Expected clinical results Exceptional bodily fluids d for a clinically unique situation are properly reported Each patient result outside of expected specimen types e.g. The reference range and other method performance specifications have not been established for this body fluid. The test result must be integrated into the clinical context for interpretation. S-003 Test is ordered outside the Limitations of Use Minor Improbable Acceptable Yes No Acceptable Retesting by a different method or device Unusual patient results Expected clinical results Exceptional bodily fluids d for a clinically unique situation are properly reported Each patient result outside of expected specimen types e.g. The reference range and other method performance specifications have not been established for this body fluid. The test result must be integrated into the clinical context for interpretation.
20 Quality Control Plan S-004 Patient is injured during collection Minor Remote Acceptable Yes No Acceptable Allen's Test is performed Per radial artery puncture Collateral circulation is verified and documented Device-related adverse events are reported By January 1st Per FDA mandatory reporting guidelines on Form 3419 or Form 3500 Care is provided to patients who experience adverse reactions from blood-letting Immediately Fainting, seizures, or injuries S-005 Sample is collected from the wrong patient Minor Improbable Acceptable Yes No Acceptable Track percent of patient wristbands with errors Track percent of ordered tests with patient identification errors Track percent of results with identification errors Track percent of patient results which are corrected
21 Quality Control Plan Two patient identifiers are checked Before collecting patient specimen Name and unique hospital number; outpatient name and date of birth S-006 Wrong patient ID is entered into the handheld Serious Improbable Acceptable Yes No Acceptable Track percent of patient wristbands with errors Track percent of ordered tests with patient identification errors Track percent of results with identification errors Track percent of patient results which are corrected Identifying labels are attached to the container At time of collection Accuracy of manual entry is monitored Manual result, demographics, and other data entry Handheld configuration option or forcing function is in place At all times Verified by the Technical Consultant S-007 Sample is mislabeled Serious Improbable Acceptable Yes No Acceptable
22 Quality Control Plan Track percent of ordered tests with patient identification errors Track percent of results with identification errors Track percent of accepted for testing Two patient identifiers are checked Identifying labels are attached to the container Before collecting patient specimen At time of collection Name and unique hospital number; outpatient name and date of birth Patient are positively identified Always Barcoded or manually labeled containers which track patient identification, collection date/time, and specimen type S-008 Collection supplies are out of tolerance, misused, or expired Minor Improbable Acceptable Yes No Acceptable Collection supplies are stored and used properly All supplies Per manufacturer's instructions and within expiry Specimen integrity is evaluated by Test personnel Every patient test
23 Quality Control Plan S-009 Sample is drawn in the wrong container type (tube, syringe, capillary tube) Minor Improbable Acceptable Yes No Acceptable Track percent of accepted for testing Specimen containers are evaluated to reduce or eliminate analytic interference Specimen integrity is evaluated by Test personnel Initial system implementation Every patient test Direct testing, clinical literature, or manufacturer information S-010 Sample is contaminated with alcohol or cleansing agent from prep Minor Improbable Acceptable Yes No Acceptable Track percent of accepted for testing Specimen integrity is evaluated by Test personnel Every patient test
24 Quality Control Plan S-011 Sample quantity is insufficient due to poor circulation or access Minor Improbable Acceptable Yes No Acceptable Track percent of accepted for testing Specimen integrity is evaluated by Test personnel Every patient test Handheld configuration option or forcing function is in place At all times Verified by the Technical Consultant S-012 Sample quantity is insufficient due to poor technique Minor Improbable Acceptable Yes No Acceptable Track percent of accepted for testing
25 Specimen integrity is evaluated by Test personnel Every patient test Handheld configuration option or forcing function is in place At all times Verified by the Technical Consultant Quality Control Plan S-013 Sample is collected by improper access method (venous, arterial, capillary) Minor Remote Acceptable Yes No Acceptable Track percent of accepted for testing Specimen integrity is evaluated by Test personnel Every patient test S-014 Syringe is not evacuated of ambient air Negligible Improbable Acceptable Yes No Acceptable
26 Quality Control Plan System to prevent ambient air contamination Per blood gas Follow established procedures Track percent of accepted for testing Specimen integrity is evaluated by Test personnel Every patient test S-015 Wrong type of container anticoagulant is selected Minor Improbable Acceptable Yes No Acceptable Track percent of accepted for testing Specimen containers are evaluated to reduce or eliminate analytic interference Specimen integrity is evaluated by Test personnel Initial system implementation Every patient test Direct testing, clinical literature, or manufacturer information
27 Quality Control Plan S-016 Sample is diluted with IV anticoagulant or fluid Minor Remote Acceptable Yes No Acceptable Track percent of accepted for testing Specimen integrity is evaluated by Test personnel Every patient test S-017 Sample is contaminated with bubbles Negligible Remote Acceptable Yes No Acceptable Track percent of accepted for testing Specimen integrity is evaluated by Test personnel Every patient test Handheld configuration option or forcing function is in place At all times Verified by the Technical Consultant
28 Quality Control Plan S-018 Sample is clotted Minor Occasional Acceptable Yes No Acceptable Track percent of accepted for testing Specimen integrity is evaluated by Test personnel Every patient test Handheld configuration option or forcing function is in place At all times Verified by the Technical Consultant S-019 Sample is not properly mixed before infusing into the cartridge Minor Improbable Acceptable Yes No Acceptable Track percent of accepted for testing Specimen integrity is evaluated by Test personnel Every patient test
29 Quality Control Plan S-020 Sample is transported or left sitting for an extended period of time Negligible Improbable Acceptable Yes No Acceptable Track percent of accepted for testing Track collection-to-reporting median turnaround time Track turnaround time outliers Specimen integrity is evaluated by Test personnel Every patient test S-021 Sample is improperly iced Minor Improbable Acceptable Yes No Acceptable Track percent of accepted for testing
30 Specimen integrity is evaluated by Test personnel Every patient test Quality Control Plan S-022 Patient test is not repeated when result does not match patient condition and therapy Minor Remote Acceptable Yes No Acceptable Retesting by a different method or device Unusual patient results Expected clinical results Hook or sampling/dilution errors are eliminated Per patient results Outside Analytical Measurement Range (AMR) Track percent of patient results which are corrected S-023 Patient is suffering from anemia or polycythemia beyond the capabilities of the test system Minor Remote Acceptable Yes No Acceptable Retesting by a different method or device Unusual patient results Expected clinical results
31 Track percent of accepted for testing Quality Control Plan Specimen integrity is evaluated by Test personnel Every patient test Handheld configuration option or forcing function is in place At all times Verified by the Technical Consultant S-024 Patient is receiving interfering drugs beyond the parameters listed in product labeling Minor Remote Acceptable Yes No Acceptable Retesting by a different method or device Unusual patient results Expected clinical results Track percent of accepted for testing Specimen integrity is evaluated by Test personnel Every patient test
32 Test System Risks Quality Control Plan T-033 Clinician fails to act on critical results Serious Remote Acceptable Remote Yes No Acceptable Track percent of critical results reported to caregivers Track percent of critical results for which the primary caregiver cannot be contacted in a reasonable period of time Critical results are reported to the caregiver Immediately Outside critical or alert limits Critical results are read back Immediately When communicated verbally This risk is covered by our Written Policy This risk is covered during our Quiz This risk is covered by our Monitoring of Results
33 Quality Assessment Quality Assessment The Code of Federal Regulations (42 CFR 493) states laboratories must establish and follow written policies and procedures for a comprehensive quality assurance program that is designed to monitor and evaluate the ongoing and overall quality of the total testing process. The QA program must: Assess the iveness of the lab s policies and procedures. Identify and correct problems. Assure the accurate, reliable, and prompt reporting of test results. Assure the adequacy and competency of the staff. CLIA Standards for Quality Assurance The regulations specify ten different standards to be included in a laboratory s quality assurance program. 1 The first standard emphasizes having a system in place for monitoring and evaluating the procedures for Patient Test Management, including: Patient preparation Specimen collection Labeling Preservation and transportation Test requisition completeness Relevance and necessity for testing Use of appropriate criteria for specimen rejection Test report completeness Relevance and accuracy Timely reporting of results Accuracy and reliability of test reporting systems Storage and retrieval of result
34 2 The second standard is quality control. The lab is to have systems in place to evaluate the iveness of corrective actions in regard to the QC program, including: Quality Assessment Problems identified during the evaluation of calibration and QC Problems identified during the evaluation of patient test results (to verify the reference range of a test method) Errors detected in results The third standard is proficiency testing. The lab is to assess the iveness of corrective action taken to address any unacceptable, unsatisfactory, or unsuccessful PT results. The fourth standard is a comparison of test results. If a laboratory has more than one method of performing the same test, the lab must (twice a year) evaluate and define the relationship between the two methods (i.e., run the same specimen by each method and check for comparable results). If the lab performs testing on non-regulated analytes, the lab must have a method for verifying the accuracy of its test results. Proficiency testing or split sampling may be used. The fifth standard involves the relationship of patient information to patient test results. This is an internal quality assurance function. The lab must have a system in place to identify and evaluate patient test results when they appear inconsistent such criteria as the patient's age, sex, diagnosis, and the relationship with other test results. The sixth standard involves personnel assessment. The laboratory must have a system in place to evaluate the iveness of its policies and procedures for assuring employee competence. If the lab has an outside consultant, the lab should have a method for evaluating his/her iveness, also. The seventh standard involves communications. The lab must have a mechanism for documenting problems arising as a result of a breakdown in communication. Corrective actions must be taken to both resolve the problem and minimize future communication breakdowns.
35 8 The eighth standard addresses complaint investigations. The lab must have a system to assure that all complaints and problems are documented. Investigations must be made and corrective action taken. Quality Assessment 9 10 The ninth standard is quality assurance review with staff. In addition to documenting and assessing problems identified in QA reviews, the lab personnel must discuss the issues and take corrective action to prevent recurrences. The tenth standard addresses QA records. Documentation of all QA activities must be made available to the Department of Health and Human Services. Certification All 10 Quality Assurance measures are employed by this laboratory
36 Quality Management Software for the clinical laboratory Designed to simplify and streamline the process of developing comprehensive IQCPs, Pro-QCP assists in meeting your goal of improving patient outcomes. Pro-QCP is an online, web-based software application which facilitates the creation of Individualized Quality Control Plans (IQCPs) consistent with CLSI EP-23 guidelines. Pro-QCP is available by annual subscription with specialized modules specific to the risks of each test device or method. Inspection-ready IQCP s Easy-to-use Saves time Fully customizable Comprehensive: Pre-analytical Analytical Post-analytical I love Pro-QCP; it s wonderful! CarePoint has done all the work in gathering the manufacturer s information. I wouldn t do my IQCP s any other way! toll free PO Box 900 Westford, MA 01886
EDUCATIONAL COMMENTARY KEY COMPONENTS OF AN INDIVIDUALIZED QUALITY CONTROL PLAN
Commentary provided by: E Susan Cease MT(ASCP) Laboratory Manager Three Rivers Medical Center Grants Pass, OR EDUCATIONAL COMMENTARY KEY COMPONENTS OF AN INDIVIDUALIZED QUALITY CONTROL PLAN Educational
More informationIQCP. Ensuring Your Laboratory s Compliance With Individualized Quality Control Plans. November/December 2016
IQCP Ensuring Your Laboratory s Compliance With Individualized Quality Control Plans November/December 2016 Objectives Describe the different components of an IQCP Review new CAP checklist requirements
More informationLearning Objectives. Individualized Quality Control Plans. Agenda. Another Way To Determine QC? Hooray!!!! What is QC?
Learning Objectives State when an IQCP is required Individualized Quality Control Plans Andy Quintenz Scientific / Professional Affairs Compare / Contrast Traditional QC approach with Risk Based QC List
More informationLaboratory Risk Assessment: IQCP and Beyond. Ron S. Quicho, MS Associate Project Director Standards and Survey Methods, Laboratory July 18, 2017
Laboratory Risk Assessment: IQCP and Beyond Ron S. Quicho, MS Associate Project Director Standards and Survey Methods, Laboratory July 18, 2017 Objectives Explain the importance of risk assessment in the
More information3/14/2016. The Joint Commission and IQCP. Objectives. Before Getting Started
The Joint Commission and IQCP Stacy Olea, MBA, MT(ASCP), FACHE Executive Director Laboratory Accreditation The Joint Commission AACC 2015 Objectives Identify the three components of IQCP Determine a starting
More informationCLIA S NEW IQCP SEABB. March 19, Linda Sigg, MT(ASCP)SBB,CQA(ASQ) Staff Lead Assessor, Accreditation, AABB
CLIA S NEW IQCP SEABB March 19, 2014 Linda Sigg, MT(ASCP)SBB,CQA(ASQ) Staff Lead Assessor, Accreditation, AABB OBJECTIVES Clinical Laboratory Improvement Amendment What is IQCP? What are the parts of IQCP.
More informationCAP Most Frequent Deficiencies and How to Avoid Them. March 11, 2015
CAP 2015 Most Frequent Deficiencies and How to Avoid Them Jean Ball MBA,MT(HHS),MLT(ASCP) Inspection Services Team Lead Laboratory Accreditation Program March 11, 2015 Objectives: Participants will be
More informationLaboratory Services. Specimen Collection & Rejection Procedure
Laboratory Services Specimen Collection & Rejection Procedure According to both the Clinical Laboratory Improvement Amendment (CLIA) regulations and the College of American Pathologist s (CAP) Accreditation
More information5/8/2015. Individualized Quality Control Plans (IQCP) Changes to the CMS Quality Requirements. CLIA Quality Control Evolution of the Process
Individualized Quality Control Plans (IQCP) Changes to the CMS Quality Requirements John Shalkham, MA, SCT(ASCP) Office of Quality Assurance Wisconsin State Laboratory of Hygiene Clinical Assistant Professor,
More informationStandards for Laboratory Accreditation
Standards for Laboratory Accreditation 2017 Edition cap.org 2017 College of American Pathologists. All rights reserved. [ T y p e t h e c o m p a n y a d d r e s s ] CAP Laboratory Accreditation Program
More informationPreanalytical Errors in Laboratory - Their Consequences and Measures to Reduce Them
Preanalytical Errors in Laboratory - Their Consequences and Measures to Reduce Them Tazeen Farooqui, Student of MBA (HM), College of Hospital Administration, TMU, Moradabad Email:-tazeenfarooqui01@gmail.com
More informationSTANDARDS Point-of-Care Testing
STANDARDS Point-of-Care Testing For Surveys Starting After: January 1, 2018 Date Generated: January 12, 2017 Point-of-Care Testing Published by Accreditation Canada. All rights reserved. No part of this
More informationPolicy Subject Index Number Section Subsection Category Contact Last Revised References Applicable To Detail MISSION STATEMENT: OVERVIEW:
Subject Objectives and Organization Pathology and Laboratory Medicine Index Number Lab-0175 Section Laboratory Subsection General Category Departmental Contact Ekern, Nancy L Last Revised 10/25/2016 References
More informationHeart of America POC Group Quality Management Making it Meaningful
Heart of America POC Group Quality Management Making it Meaningful Maximize Your Existing Quality Management System to Deliver Greater Value Georgine Paulus, BSMT(ASCP) Senior Staff Inspector College of
More informationCLIA s New IQCP Requirements Are in Effect, or Are They?: Implementing Laboratory Risk Management Now to Ensure Success
CLIA s New IQCP Requirements Are in Effect, or Are They?: Implementing Laboratory Risk Management Now to Ensure Success Jack Zakowski, PhD, FACB Director, Scientific Affairs and Professional Relations
More informationIndividualized Quality Control Plan (IQCP) Frequently Asked Questions Date: May 5, 2015 (last updated 08/21/2017)
Topic: Individualized Quality Control Plan (IQCP) Frequently Asked Questions Date: May 5, 2015 (last updated 08/21/2017) Click on the links below to be taken to a specific section of the FAQs. General
More informationCAP Forensic Drug Testing Accreditation Program Standards for Accreditation
CAP Forensic Drug Testing Accreditation Program Standards for Accreditation Preamble Forensic drug testing is a laboratory specialty concerned with the testing of urine, oral fluid, hair, and other specimens
More informationPlan for Quality to Improve Patient Safety at the POC
Plan for Quality to Improve Patient Safety at the POC SHARON S. EHRMEYER, PH.D., MT(ASCP) PROFESSOR, DEPARTMENT OF PATHOLOGY AND LABORATORY MEDICINE SCHOOL OF MEDICINE AND PUBLIC HEALTH MADISON, WI = Quality
More informationPerformance of Point-of-Care Testing in Unaccredited Settings:
Performance of Point-of-Care Testing in Unaccredited Settings: A Guideline for Non-Laboratorians Prepared by the Advisory Committee on Laboratory Medicine College of Physicians & Surgeons of Alberta You
More informationPatient Safety (PS) 1) A collaborative process is used to develop policies and/or procedures that address the accuracy of patient identification.
Patient Safety (PS) Standard PS.1 [Patient identification] The organization has established procedures for accurately identifying patients. Intent of PS.1 Wrong-patient errors occur in virtually all aspects
More informationIQCP January Is Coming Fast What Do I Do?!? Jean Ball Bold, MBA, MT(HHS), MLT(ASCP
IQCP January Is Coming Fast What Do I Do?!? Jean Ball Bold, MBA, MT(HHS), MLT(ASCP December 3, 2015 Objectives Define what IQCP is Explain what the requirements are Learn the steps to formulate an IQCP
More informationPoint of Care Quality Management. Procedure. Approving Authority: President and CEO, Keith Dewar
Subject/Title Point of Care Quality Management Procedure Approving Authority: President and CEO, Keith Dewar Manual: Reference Number: 812-1 Effective Date: Dec 6 th, 2016 Revision Dates: Classification:
More informationMartin Health System Stuart, Florida Laboratory Services. Laboratory Services and Policies
Martin Health System Stuart, Florida Laboratory Services Laboratory Services and Policies Service Commitment: It is the goal of the Martin Health System s Clinical Laboratory to provide the medical community
More informationPreventing Medical Errors
Presents Preventing Medical Errors Contact Hours: 2 First Published: March 31, 2017 This Course Expires on: March 31, 2019 Course Objectives Upon completion of this course, the nurse will be able to: 1.
More informationStandards for Forensic Drug Testing Accreditation
Standards for Forensic Drug Testing Accreditation 2013 Edition cap.org Forensic Drug Testing Accreditation Program Standards for Accreditation 2013 Edition Preamble Forensic drug testing is a laboratory
More informationThe Lab General Checklist
The Lab General Checklist Lab General 129 potential pages of fun! Customized to your lab and lab services so probably more like 50 for RLAP. The Laboratory General (GEN) Checklist applies to all sections
More informationExample of a Health Care Failure Mode and Effects Analysis for IV Patient Controlled Analgesia (PCA) Failure Modes (what might happen)
Prescribing Assess patient Choose analgesic/mode of delivery Prescribe analgesic Institute for Safe Medication Practices Example of a Health Care and Effects Analysis for IV Patient Controlled Analgesia
More informationRESPIRATORY PROTECTION PROGRAM
RESPIRATORY PROTECTION PROGRAM 1.0 PURPOSE The purpose of this Respiratory Protection Program is to protect respirator users at California State University East Bay from breathing harmful airborne contaminants
More informationQuality Assurance Program For Hospital Based Point of Care Testing. Presented by: Jeanne Mumford, MT(ASCP) Pathology Supervisor, QA Specialist
Quality Assurance Program For Hospital Based Point of Care Testing Presented by: Jeanne Mumford, MT(ASCP) Pathology Supervisor, QA Specialist 1 Objectives At the end of the session, participants will be
More informationCOPY. That all specimens received by the lab are properly labeled by person collecting the specimen
Current Status: Active PolicyStat ID: 3609063 Origination: 07/2015 Last Approved: 11/2017 Last Revised: 07/2015 Next Review: 11/2019 Owner: Anne Harr: Supervisor, Lab Support Svc Policy Area: PCS: Pathology
More informationTHE VALUE OF CAP S Q-PROBES & Q-TRACKS
THE VALUE OF CAP S Q-PROBES & Q-TRACKS Peter J. Howanitz MD Professor, Vice Chair, Laboratory Director Dept. Of Pathology SUNY Downstate Brooklyn, NY 11203, USA Peter.Howanitz@downstate.edu OVERVIEW Discuss
More informationPersonnel. From RLM, COM, GEN and TLC Checklists
Personnel From RLM, COM, GEN and TLC Checklists The laboratory should have an organizational plan, personnel policies, and job descriptions that define qualifications and duties for all positions. Personnel
More informationQC Explained Quality Control for Point of Care Testing
QC Explained 1.0 - Quality Control for Point of Care Testing Kee, Sarah., Adams, Lynsey., Whyte, Carla J., McVicker, Louise. Background Point of care testing (POCT) refers to testing that is performed
More informationMaster. Point-of-Care-Testing Checklist. CAP Accreditation Program
Master Point-of-Care-Testing Checklist CAP Accreditation Program College of American Pathologists 325 Waukegan Road Northfield, IL 60093-2750 www.cap.org 08.17.2016 2 of 33 Disclaimer and Copyright Notice
More informationTESTIMONY OF THOMAS HAMILTON DIRECTOR SURVEY & CERTIFICATION GROUP CENTER FOR MEDICAID AND STATE OPERATIONS CENTERS FOR MEDICARE & MEDICAID SERVICES
TESTIMONY OF THOMAS HAMILTON DIRECTOR SURVEY & CERTIFICATION GROUP CENTER FOR MEDICAID AND STATE OPERATIONS CENTERS FOR MEDICARE & MEDICAID SERVICES ON CLIA AND GENETIC TESTING BEFORE THE SENATE SPECIAL
More information: Suzanna Immanuel Place, date of birth : Jakarta, 11 th March 1953 Education : MD FMUI 1978 Profession : Clinical Pathologist (SpPK) FMUI 1984
Name : Suzanna Immanuel Place, date of birth : Jakarta, 11 th March 1953 Education : MD FMUI 1978 Profession : Clinical Pathologist (SpPK) FMUI 1984 Consultant [SpPK(K)] ISCP (PDSPatKlin) 1996 Office :
More informationSUCCESSION PLANNING: FILLING A LABORATORY DIRECTOR S SHOES PART ONE
JANUARY / FEBRUARY 09 SUCCESSION PLANNING: FILLING A LABORATORY DIRECTOR S SHOES PART ONE By Karen Appold When someone leaves a laboratory director position, or any job for that matter, it could be for
More informationPROGRAM GUIDE - UNIVERSITY CLIA REGISTERED LABORATORIES COMPLIANCE COMMITTEE
PROGRAM GUIDE - UNIVERSITY CLIA REGISTERED LABORATORIES COMPLIANCE COMMITTEE 1 P age GUIDELINES - UNIVERSITY CLIA REGISTERED LABORATORIES COMPLIANCE COMMITTEE AND PROGRAM I. Introduction II. Committee
More informationMaster. Point-of-Care-Testing Checklist. CAP Accreditation Program
Master Point-of-Care-Testing Checklist CAP Accreditation Program College of American Pathologists 325 Waukegan Road Northfield, IL 60093-2750 www.cap.org 08.21.2017 2 of 33 Disclaimer and Copyright Notice
More informationDominic Cox Royal Free Hospital London Joan Pearson Leeds General Infirmary
POINT OF CARE TESTING (POCT) IN CRITICAL CARE Authors: Dominic Cox Royal Free Hospital London Joan Pearson Leeds General Infirmary In collaboration with ICS standards committee Introduction Point of Care
More informationSPECIMEN REQUIREMENTS
SPECIMEN REQUIREMENTS General Guidelines for Specimen Handling Specimen requirements generally include the requested volume, storage temperature, and any special handling notes. The requested volume provides
More informationLABORATORY SPECIMEN ID REPORT FEBRUARY 2018
LABORATORY SPECIMEN ID REPORT FEBRUARY 2018 LABORATORY SPECIMEN ID REPORT 3 CONTENTS I. Executive Summary... 4 II. Survey Demographics... 5 III. Response Analysis a. Laboratory Priorities... 6 b. Specimen
More informationSpecimen Collection Regulations and Standards
Specimen Collection Regulations and Standards Stacy Olea, FACHE, MBA, MT(ASCP) Field Director Accreditation and Certification Operations The Joint Commission Scope Specimen collection could be occurring:
More informationOrganization for Economic Co-operation and Development
IGLP document -IRAQ- BAGHDAD English - Or. Arabic Unclassified Organization for Economic Co-operation and Development (2015) 21-Dec-2015 According to criteria of OECD ON TESTING AND CALIBRATION Number
More informationPatient Safety. If you have any questions, contact: Sheila Henssler Performance Improvement/Patient Safety Coordinator Updated:
Patient Safety If you have any questions, contact: Sheila Henssler Performance Improvement/Patient Safety Coordinator 615-7018 Updated: 2013-05-03 Learning Objectives In this presentation, you will learn:
More informationDisclosures. Relevant Financial Relationship(s): Nothing to Disclose. Off Label Usage: Nothing to Disclose 6/1/2017. Quality Indicators
Laurie Griesmann, Quality Specialist May 17, 2017 Disclosures Relevant Financial Relationship(s): Nothing to Disclose Off Label Usage: Nothing to Disclose 1 Objectives Define a quality indicator. Recognize
More informationINTRODUCTION TO HACCP
INTRODUCTION TO HACCP NINA G. PARKINSON NGP CONSULTING NOVEMBER 12, 2014 NGP Consulting Nov 2014 1 COMMENTS FROM 2013 Waaay too much information! Didn t even get to the end with FSMA stuff! Basic, but
More informationCompounded Sterile Preparations Pharmacy Content Outline May 2018
Compounded Sterile Preparations Pharmacy Content Outline May 2018 The following domains, tasks, and knowledge statements were identified and validated through a role delineation study. The proportion of
More informationReport accurate, timely laboratory results to clinical staff
PERFORMANCE PLAN PHD Matthew Bolssen x5616 Program Purpose Report accurate, timely laboratory results to clinical staff Program Information Operated in two sites: Fenwick and Sequoia. In the fall 2015,
More informationPatient Safety Overview
Patient Safety Overview Muhammad H. Islam, MBBS, MS, MCH, LSSBB Director of Patient Safety & Patient Safety Officer SUNY Downstate Medical Center, UHB www.downstate.edu/patientsafety Definitions Patient
More informationMaster. Point-of-Care-Testing Checklist. Every patient deserves the GOLD STANDARD... CAP Accreditation Program
Master Every patient deserves the GOLD STANDARD... Point-of-Care-Testing Checklist CAP Accreditation Program College of American Pathologists 325 Waukegan Road Northfield, IL 60093-2750 www.cap.org 07.28.2015
More informationCE Update [generalist compliance/regulation management/administration and training] COLA Accreditation An Educational Experience
your lab focus 284 CE Update [generalist compliance/regulation management/administration and training] COLA Accreditation An Educational Experience Jennifer L. Rivers, Catherine M. Johnson, MT(ASCP) COLA,
More informationThe CAP Inspection Process
The CAP Inspection Process So you ve accepted an inspection assignment Inspector s Inspection Packet sent from CAP 3 6 months prior to lab s anniversary date Inspection must occur within 3 month window
More informationUPMC POLICY AND PROCEDURE MANUAL
UPMC POLICY AND PROCEDURE MANUAL POLICY: INDEX TITLE: HS-PT1200 Patient Safety SUBJECT: Reportable Patient Events DATE: December 4, 2015 I. POLICY It is the policy of UPMC to encourage and promote a philosophy
More informationAdministrative Policies and Procedures. Policy No.: N/A Title: Medical Equipment Management Plan
Administrative Policies and Procedures Originating Venue: Environment of Care Title: Medical Equipment Management Plan Cross Reference: Date Issued: 11/14 Date Reviewed: Date: Revised: Attachment: Page
More informationCAP Accreditation and Checklists Update. Lyn Wielgos, MT(ASCP) Checklist Editor, CAP Accreditation Programs
CAP Accreditation and Checklists Update Lyn Wielgos, MT(ASCP) Checklist Editor, CAP Accreditation Programs November 3, 2017 Objectives Discuss CAP Checklists and highlight changes in the 2017 checklist
More informationControlling Office: Director of Clinical Services Effective Date: May 1, Applies to CAMTS: n/a Last Review: January 1, 2018
Statement of Policy Respiratory Program Policy #: SMS-022 Controlling Office: Director of Clinical Services Effective Date: May 1, 2013 Applies to CAMTS: n/a Last Review: January 1, 2018 Policy About 32
More informationSTANDARDIZED PROCEDURE FEMORAL VENOUS BLOOD DRAW (Adult, Peds)
I. Definition The Femoral venous blood draw (FVBD) is the procedure of performing a needle stick into the femoral vein for the purpose of drawing blood work that will assist in lab monitoring. II. Background
More informationBest Practices for Equipment Calibration and Analytical Controls in the Diagnostics Laboratory
Best Practices for Equipment Calibration and Analytical Controls in the Diagnostics Laboratory George Rodrigues, Artel (slides 2-16) Rebecca Butler, CareDx (slides 17-29) Agenda Agenda Theory / Regulations
More informationObjectives. With the completion of this module the learner will:
Specimen Labeling Objectives With the completion of this module the learner will: Identify the appropriate procedure for collecting and labeling specimens. Define patient identification requirements at
More informationPURPOSE: This policy provides an overview of SHANDS Jacksonville Laboratory s commitment to the care and safety of the patients we serve.
PAGE 1 of 5 TITLE: Provision of Care Regarding Laboratory Services PURPOSE: This policy provides an overview of SHANDS Jacksonville Laboratory s commitment to the care and safety of the patients we serve.
More informationThe CLIA regulations..
Julia H. Appleton MT(ASCP), MBA Centers for Medicare & Medicaid Services (CMS) Center for Clinical Standards and Quality (CCSQ) Division of Laboratory Services (DLS) April 13, 2017 Objectives Explain an
More informationSAMPLE. Statistical Quality Control for Quantitative Measurement Procedures: Principles and Definitions
4th Edition C24 Statistical Quality Control for Quantitative Measurement Procedures: Principles and Definitions This guideline provides definitions, principles, and approaches to laboratory quality control
More informationRegulatory,Quality & Emergency Preparedness. MaryBeth Parache Director, Quality Affairs New York Blood Center
Regulatory,Quality & Emergency Preparedness MaryBeth Parache Director, Quality Affairs New York Blood Center 1 Regulatory 2 Who regulates us? Food and Drug Administration (FDA) Blood, tissue, HCT/P, medical
More informationhttps://e-dition.jcrinc.com/common/popups/printchapter.aspx?rwndrnd=
Page 1 of 9 Effective ate: January 9, 2017 Overview: A laboratory test is an activity that evaluates a substance(s) removed from a human body and translates that evaluation into a result. A result can
More informationUPMC POLICY AND PROCEDURE MANUAL
UPMC POLICY AND PROCEDURE MANUAL POLICY: INDEX TITLE: HS-PT1200 Patient Safety SUBJECT: Reportable Patient Events DATE: September 9, 2013 I. POLICY It is the policy of UPMC to encourage and promote a philosophy
More informationCOMMISSION ON LABORATORY ACCREDITATION. Laboratory Accreditation Program TEAM LEADER ASSESSMENT OF DIRECTOR & QUALITY CHECKLIST
Revised: 09/27/2007 COMMISSION ON LABORATORY ACCREDITATION Laboratory Accreditation Program TEAM LEADER ASSESSMENT OF DIRECTOR & QUALITY CHECKLIST Disclaimer and Copyright Notice The College of American
More informationCAMH February 2005 Update HIGHLIGHTS
CAMH February 2005 Update HIGHLIGHTS STANDARD UP 1. How to Use Manual Multiple changes to scoring, category changes and Measure of Success (MOS) designation removed 2. Accreditation Policies & Procedures
More informationSample. A guide to development of a hospital blood transfusion Policy at the hospital level. Effective from April Hospital Transfusion Committee
Sample A guide to development of a hospital blood transfusion Policy at the hospital level Name of Policy Blood Transfusion Policy Effective from April 2009 Approved by Hospital Transfusion Committee A
More informationPatient Safety Overview Muhammad H. Islam, MBBS, MS, MCH Director of Patient Safety & Patient Safety Officer SUNY Downstate Medical Center, UHB
Patient Safety Overview Muhammad H. Islam, MBBS, MS, MCH Director of Patient Safety & Patient Safety Officer SUNY Downstate Medical Center, UHB www.downstate.edu/patientsafety Definitions Patient Safety
More informationManager. 2. To establish procedures for selecting and acquiring biomedical equipment.
Page 1 of 8 CENTRAL STATE HOSPITAL POLICY SUBJECT: BIOMEDICAL EQUIPMENT MANAGEMENT ANNUAL REVIEW MONTH: RESPONSIBLE FOR REVIEW: October Regional Safety & Environmental Health Manager LAST REVISION DATE:
More informationDefinitions: In this chapter, unless the context or subject matter otherwise requires:
CHAPTER 61-02-01 Final Copy PHARMACY PERMITS Section 61-02-01-01 Permit Required 61-02-01-02 Application for Permit 61-02-01-03 Pharmaceutical Compounding Standards 61-02-01-04 Permit Not Transferable
More informationFaculty of Science Risk Assessment Procedure
Faculty of Science Risk Assessment Procedure Version 1.0 TRIM file number 11/ Faculty of Science Doc No Short description Relevant to Authority Responsible officer Responsible office Procedure outlining
More informationTITLE 252. DEPARTMENT OF ENVIRONMENTAL QUALITY CHAPTER 302. FIELD LABORATORY ACCREDITATION
Codification through the 2014 Legislative session. Subchapter 9 Board adoption - November 13, 2013 Approved by Governor's declaration on June 19, 2014 Effective date - September 12, 2014 TITLE 252. DEPARTMENT
More informationTutorial: Basic California State Laboratory Law
Tutorial: Basic California State Laboratory Law This document is meant to cover basic elements of state laboratory law and should not be relied upon in place of legal advice or the official codes of California.
More informationQMP-LS: A Canadian Regional EQA Program How Labs Get In and Out of Trouble in Ontario
QMP-LS: A Canadian Regional EQA Program How Labs Get In and Out of Trouble in Ontario Anne Raby Mayo/NASCOLA Coagulation Testing Quality Conference April 14 th, 2009 2 Disclosure Relevant Financial Relationship(s)
More informationReferral Laboratories
Introduction: A clinical laboratory often requires the assistance of an outside facility or facilities to perform unique or unusual services, as a backup service, or for routine services that the referring
More informationDIAGNOSTIC CLINICAL TESTS AND SCREENING PROCEDURES MANAGEMENT POLICY
DIAGNOSTIC CLINICAL TESTS AND SCREENING PROCEDURES MANAGEMENT POLICY (To be read in conjunction with Diagnostic Imaging Requesting and Interpreting Radiographs by Non Medical Practitioners Policy, Consent
More informationClinical and Laboratory Standards Institute: Addressing POCT Needs; The Good, The Bad, and The Risky
Clinical and Laboratory Standards Institute: Addressing POCT Needs; The Good, The Bad, and The Risky Marcy Anderson MS, MT(ASCP) Director, Education 3 Rivers POCT Network June 7, 2012 Today s Presentation
More informationWalking the Tightrope with a Safety Net Blood Transfusion Process FMEA
Walking the Tightrope with a Safety Net Blood Transfusion Process FMEA AnMed Health AnMed Health, located in Anderson, South Carolina, is one of the largest and most technologically advanced health systems
More informationPOINT OF CARE TESTING POLICY Page 1 of 6 Reviewed: October 2017
Page 1 of 6 Policy Applies to: All clinical staff involved in using Point of Care Testing (POCT) equipment. Related Standards: Health & Disability Standard 4.2.3 Amenities, fixtures, equipment and furniture
More informationTo: Prefectural Governors From: Director General, Pharmaceutical and Food Affairs Bureau, Ministry of Health, Labour and Welfare
This draft English translation of notification on GLP has been made by JSQA. JSQA translated them with particular care to accuracy, but does not guarantee that there are no differences in the delicate
More informationPrepublication Requirements
Issued Prepublication Requirements The Joint Commission has approved the following revisions for prepublication. While revised requirements are published in the semiannual updates to the print manuals
More informationSHRI GURU RAM RAI INSTITUTE OF TECHNOLOGY AND SCIENCE MEDICATION ERRORS
MEDICATION ERRORS Patients depend on health systems and health professionals to help them stay healthy. As a result, frequently patients receive drug therapy with the belief that these medications will
More informationHealth Science Career Cluster Diagnostics Phlebotomy Course Number:
Health Science Career Cluster Diagnostics Phlebotomy Course Number: 25.57400 Course Description: This course is designed to help students become prepared for the phlebotomy technician certification exam,
More informationInternal Lab Inspections: Are You Inspection Ready? Presented by: Jeanne Mumford, MT(ASCP) Manager, Point of Care Testing, JHM
Internal Lab Inspections: Are You Inspection Ready? Presented by: Jeanne Mumford, MT(ASCP) Manager, Point of Care Testing, JHM Speaker Introductions Jeanne Mumford, MT(ASCP) Manager, Point of Care Testing
More informationPOLICY/PROCEDURE PLAN GUIDELINE. SECTION: I Administrative
TITLE: Patient Safety Occurrence Report POLICY PTCADM100.23 SCOPE: Children's Hospital of Pittsburgh ("CHP") Main Children's Hospital of Pittsburgh Satellites Children's Hospital of Pittsburgh Ambulatory
More informationProfiles in CSP Insourcing: Tufts Medical Center
Profiles in CSP Insourcing: Tufts Medical Center Melissa A. Ortega, Pharm.D., M.S. Director, Pediatrics and Inpatient Pharmacy Operations Tufts Medical Center Hospital Profile Tufts Medical Center (TMC)
More informationCarter Healthcare, Inc
PURPOSE WAIVED TESTING Policy No. 2-047 To define the organization's compliance with waived testing criteria and the need for a certificate of laboratory services. POLICY The Clinical Laboratory Improvement
More informationSubject: Quality Management for Origin date: 3/06 Point of Care and Waived Testing Reviewed: 2009 /2010 Revised: 2/2009
LOURDES HOSPITAL 169 Riverside Drive Binghamton, New York 13905 Subject: Quality Management for Origin date: 3/06 Point of Care and Waived Testing Reviewed: 2009 /2010 Revised: 2/2009 Introduction: This
More informationPsychological Specialist
Job Code: 067 Psychological Specialist Overtime Pay: Ineligible This is work performing psychological assessments or counseling students. Administers intelligence and personality tests. Provides consultation
More informationBest Practices for MANAGING MEDICAL EQUIPMENT AND SUPPLIES
1.5 HOURS Continuing Education Best Practices for MANAGING MEDICAL EQUIPMENT AND SUPPLIES Stored in a Vehicle Mary McGoldrick, MS, RN, CRNI Bubbles Photolibrary/Alamy Home care clinicians often have to
More informationPreliminary Assessment on Request for Licensure Medical Laboratory Science Professionals Summary of Testimony and Evidence.
Sunrise Application Review Docket No. MLSP-01-0709 Preliminary Assessment on Request for Licensure Medical Laboratory Science Professionals Summary of Testimony and Evidence Background Medical Laboratory
More information3/30/2015. Objectives. Cooking Up a QAPI: Recipe for Success Under the new COPs Part 1
Cooking Up a QAPI: Recipe for Success Under the new COPs Part 1 Catherine Gill, MS, PT, MHA Director, North Kansas City Hospital Home Health Teresa Northcutt, BSN, RN, COS-C, HCS-D Consultant Objectives
More information3. Does the institution have a dedicated hospital-wide committee geared towards the improvement of laboratory test stewardship? a. Yes b.
Laboratory Stewardship Checklist: Governance Leadership Commitment It is extremely important that the Laboratory Stewardship Committee is sanctioned by the hospital leadership. This may be recognized by
More informationThe Joint Commission Medication Management Update for 2010
Learning Objectives The Joint Commission Medication Management Update for 2010 U.S. Army Medical Command Fort Sam Houston, TX Describe most recent changes in The Joint Commission (TJC) Accreditation Program
More informationStandards for the Operation of Licensed Pharmacies
Standards for the Operation of Licensed Pharmacies Introduction These standards are made under the authority of Section 29.1 of the Pharmacy and Drug Act. They are one component of the law that governs
More informationRoyal Wolverhampton Hospitals NHS Trust. Job Description Haematology
Royal Wolverhampton Hospitals NHS Trust Job Description Haematology Job Title: Grade: A4C Band 3 (Point 7) Directorate: Pathology Department: Haematology Reports to: BMS staff and section senior Professionally
More informationSARASOTA MEMORIAL HOSPITAL
SARASOTA MEMORIAL HOSPITAL TITLE: NURSING PROCEDURE BLOOD CULTURE COLLECTION PROCEDURE (spe20) DATE: REVIEWED: PAGES: 6/10 9/18 1 of 6 PS1094 ISSUED FOR: Nursing/Lab RESPONSIBILITY: RN, LPN II, select
More informationPOCKET GUIDE TO THE ACCREDITATION STANDARDS (ISO 15189:2014)
(GLENMARIE BRANCH) POCKET GUIDE TO THE ACCREDITATION STANDARDS (ISO 15189:2014) Know the requirement!! Prepared by: Dr.Lily Manorammah Contents INTRODUCTION:... 3 OUR STRATEGY... 3 MANAGEMENT REQUIREMENTS...
More information